Related Experiment Video

Updated: Aug 18, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Hepatic impairment in fetuses of preeclamptic mothers

C Lox1, A Harral, J J Corrigan

  • 1Department of Obstetrics and Gynecology, Texas Technical University, Lubbock.

Biology of the Neonate
|January 1, 1990
PubMed

Insights

Preeclampsia is linked to lower levels of key vitamin K-dependent proteins in cord blood, including factors II, IX, and protein C, and albumin. These reductions likely stem from decreased synthesis, not vitamin K deficiency.

Area of Science:

  • Biochemistry
  • Obstetrics
  • Hematology

Background:

  • Preeclampsia is a pregnancy complication characterized by high blood pressure.
  • Vitamin K is essential for synthesizing several blood clotting factors.
  • Alterations in vitamin K-dependent proteins may occur in preeclamptic pregnancies.

Purpose of the Study:

  • To investigate levels of specific vitamin K-dependent proteins and other proteins in cord blood from preeclamptic and normal gestations.
  • To determine if observed protein level changes are indicative of vitamin K deficiency.

Main Methods:

  • Analysis of cord blood samples from preeclamptic and normal pregnancies.
  • Quantification of vitamin K-dependent proteins (factors II, VII, IX, X, protein C) and other proteins (fibrinogen, albumin).

Main Results:

  • Factor II, factor IX, protein C, and albumin levels were significantly reduced in the preeclamptic group.
  • Fibrinogen and factor X protein levels showed no significant change between groups.
  • The pattern of reduction suggests impaired protein synthesis rather than vitamin K deficiency.

Conclusions:

  • Cord blood from preeclamptic pregnancies exhibits reduced levels of certain vitamin K-dependent proteins and albumin.
  • The findings suggest decreased protein synthesis as the cause, not a systemic vitamin K deficiency.
  • Further research into the mechanisms of protein synthesis regulation in preeclampsia is warranted.

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...